According to a recent report by Western Standard, Canadian Health Minister Mark Holland has issued a controversial ministerial order that as of Wednesday (the 28th), Canadians can only purchase nicotine pouches at pharmacies.
The directive has sparked criticism because it makes it harder for smokers to access these smoking cessation products, while other cessation aids remain widely available.
Eric Gagnon, Vice President of Corporate and Regulatory Affairs at Imperial Tobacco Canada (ITCAN), stated that...
Today is a sad day for Canadian smokers who are hoping to quit. It is an abuse of power as the Minister of Health unilaterally imposed new regulations on our smoking cessation product ZONNIC. These regulations do not apply to any other smoking cessation product and specifically target ZONNIC. This is a personal attack by the minister on our company and will only make it harder for adult smokers to quit.
Kanon pointed out that other nicotine replacement therapies (NRTs) have not been affected by the ban. Despite at least five meetings between a major pharmaceutical company in the NRT market and the Ministry's office after the launch of ZONNIC, ITCAN was denied similar meetings.
Furthermore, Ganong stated that a public opinion survey conducted by the Canadian Ministry of Health in January showed that the illegal nicotine pouch brand recognized by Canadian young people is not ZONNIC, but another well-known illegal nicotine pouch brand. However, the minister's directive does not specifically address the issue of nicotine pouch use among young people, contradicting the minister's commitment to protecting young people.
The Canadian Department of Health is well aware that the nicotine pouch market has been overrun by illegal sellers. There are many active online and specialty stores selling these products, and the minister's orders will not make them disappear. In fact, illegal sales are expected to continue to increase.
In addition, Jiang emphasized that ITCAN has taken measures beyond product licensing requirements to ensure that ZONNIC is stored behind the counter and only sold after age verification. Despite facing opposition, ITCAN has complied with the new regulations and instructed its convenience store, gas station, and grocery store partners to remove its product ZONNIC from shelves.
We will provide strong support to our pharmacy partners as they are now on the front line of smoking cessation counseling.
ZONNIC is a nicotine pouch brand under the Imperial Tobacco Canada (ITCAN) company.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
